Found "Vaccines": 76 results
Sort by
Relevance

Using HTA to inform R&D: The Case of Total Systems Effectiveness

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun

Beyond coverage decisions – Using HTA to link technology supply and population health demand

Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program. This process is required to be transparent, accountable a

Advancing Universal Health Coverage Through Health Technology Assessment (HTA) – A Perspective from Kerala

The 2019 National University of Singapore (NUS) Initiative to Improve Health in Asia Leadership Development Programme (NIHA LDP) was held at NUS, Singapore from the 24th – 29th June. The event aimed to equip policy-makers with an understanding of  health technology assessment (HTA) for health care p

China using Health Technology Assessment to guide healthcare policy making is the right direction!

Partners from the International Decision Support Initiative (iDSI) join the 2nd China Health Technology Assessment Conference organised by the China National Health Development Research Center (CNHDRC) on 26-27 October 2019 in Beijing, China. The event brings together China’s high-level representati

Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop: From participant’s perspective

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e

What the Role of HTA in Healthcare Systems should be after COVID-19?

The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the

Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Overcoming Barriers: Financing and Service Delivery for Vaccination in Fragile and Conflict-Affected States

Vaccination is a critical and cost-effective public health intervention that significantly reduces child mortality. Since the inception of the World Health Organization’s Expanded Program on Immunization (WHO-EPI) in 1974, vaccines have saved millions of lives, with a Lancet study highlighting that

HPV vaccine found safe in large study

(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.“This analysis was v

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces
10 / Page